Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Eton Pharmaceuticals, Inc.(ETON) | 2,860,000 | 2,440,000 | -420,000 | $103.53M | $125.64M | 14.15% | +$22.10M |
| Disc Medicine, Inc.(IRON) | 855,000 | 1,095,000 | +240,000 | $62.53M | $71.68M | 8.07% | +$9.14M |
| Harrow, Inc.(HROW) | 2,400,000 | 2,105,000 | -295,000 | $101.93M | $64.83M | 7.30% | -$37.09M |
| Liquidia Corporation(LQDA) | 2,447,500 | 2,110,000 | -337,500 | $195.14M | $63.85M | 7.19% | -$131.29M |
| UroGen Pharma Ltd.(URGN) | 1,439,996 | 1,439,996 | 0 | $52.99M | $58.51M | 6.59% | +$5.52M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 500,000 | 555,000 | +55,000 | $37.07M | $41.23M | 4.64% | +$4.16M |
| MeiraGTx Holdings plc(MGTX) | 3,550,000 | 3,600,000 | +50,000 | $47.96M | $39.60M | 4.46% | -$8.36M |
| TG Therapeutics, Inc.(TGTX) | 535,000 | 557,000 | +22,000 | $29.39M | $31.07M | 3.50% | +$1.68M |
| Alpha Cognition Inc | 2,895,467 | 3,303,904 | +408,437 | $20.91M | $29.74M | 3.35% | +$8.83M |
| Immix Biopharma Inc | 2,345,000 | 2,825,000 | +480,000 | $24.18M | $29.39M | 3.31% | +$5.22M |
| Crescent Biopharma Inc. | 1,319,351 | 1,645,984 | +326,633 | $23.75M | $24.01M | 2.71% | +$266.6K |
| Verastem, Inc.(VSTM) | 1,800,000 | 2,753,333 | +953,333 | $6.88M | $22.16M | 2.50% | +$15.29M |
| Revolution Medicines, Inc.(RVMD) | 100,000 | 100,000 | 0 | $18.73M | $20.53M | 2.31% | +$1.80M |
| Replimune Group, Inc.(REPL) | 1,384,993 | 1,384,993 | 0 | $15.33M | $18.34M | 2.07% | +$3.00M |
| Stoke Therapeutics, Inc.(STOK) | 700,000 | 692,181 | -7,819 | $22.90M | $18.00M | 2.03% | -$4.91M |
| Summit Therapeutics Inc.(SMMT) | 0 | 1,051,901 | +1,051,901 | $0 | $17.79M | 2.00% | +$17.79M |
| Rezolute Inc | 6,300,000 | 4,087,045 | -2,212,955 | $32.76M | $16.92M | 1.91% | -$15.84M |
| Biohaven Ltd.(BHVN) | 77,915 | 1,190,000 | +1,112,085 | $1.16M | $15.89M | 1.79% | +$14.73M |
| Protagonist Therapeutics Inc | 100,000 | 100,000 | 0 | $12.26M | $14.09M | 1.59% | +$1.83M |
| Monte Rosa Therapeutics Inc | 745,000 | 1,035,000 | +290,000 | $18.03M | $12.35M | 1.39% | -$5.68M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 122,500 | 122,500 | 0 | $13.60M | $11.66M | 1.31% | -$1.94M |
| Q32 Bio Inc | 931,000 | 1,120,000 | +189,000 | $11.86M | $9.26M | 1.04% | -$2.60M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 0 | 230,000 | +230,000 | $0 | $9.03M | 1.02% | +$9.03M |
| Editas Medicine Inc | 3,861,930 | 3,486,452 | -375,478 | $12.51M | $8.96M | 1.01% | -$3.55M |
| Alumis Inc | 550,000 | 1,001,900 | +451,900 | $15.48M | $7.40M | 0.83% | -$8.07M |
| Edgewise Therapeutics, Inc.(EWTX) | 500,000 | 175,000 | -325,000 | $20.32M | $7.11M | 0.80% | -$13.21M |
| Grace Therapeutics Inc | 0 | 2,798,167 | +2,798,167 | $0 | $6.02M | 0.68% | +$6.02M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 315,171 | +315,171 | $0 | $5.93M | 0.67% | +$5.93M |
| Gossamer Bio Inc | 0 | 426,989 | +426,989 | $0 | $5.06M | 0.57% | +$5.06M |
| Adc Therapeutics SaSHS | 700,000 | 4,070,819 | +3,370,819 | $749.0K | $4.97M | 0.56% | +$4.22M |
| Jasper Therapeutics Inc | 0 | 280,808 | +280,808 | $0 | $4.89M | 0.55% | +$4.89M |
| 4d Molecular Therapeutics In | 334,437 | 334,437 | 0 | $4.45M | $4.79M | 0.54% | +$337.8K |
| Inhibrx Biosciences, Inc.(INBX) | 20,291 | 45,500 | +25,209 | $1.92M | $4.55M | 0.51% | +$2.63M |
| Cabaletta Bio Inc | 3,863,800 | 2,321,602 | -1,542,198 | $12.02M | $4.46M | 0.50% | -$7.56M |
| Trevi Therapeutics, Inc.(TRVI) | 310,000 | 310,000 | 0 | $5.78M | $4.44M | 0.50% | -$1.34M |
| Voyager Therapeutics Inc | 1,185,000 | 1,630,000 | +445,000 | $4.15M | $4.37M | 0.49% | +$220.9K |
| Zentalis Pharmaceuticals Inc | 1,412,656 | 1,412,656 | 0 | $6.85M | $3.91M | 0.44% | -$2.94M |
| Ocular Therapeutix, Inc.(OCUL) | 600,000 | 506,436 | -93,564 | $5.89M | $3.88M | 0.44% | -$2.01M |
| Relmada Therapeutics Inc | 935,000 | 1,000,000 | +65,000 | $6.47M | $3.77M | 0.42% | -$2.70M |
| Annexon Inc | 1,714,451 | 875,000 | -839,451 | $9.79M | $3.70M | 0.42% | -$6.09M |
| Opus Genetics Inc | 1,125,000 | 750,000 | -375,000 | $4.62M | $3.63M | 0.41% | -$993.8K |
| Codexis Inc | 6,785,000 | 2,590,000 | -4,195,000 | $15.33M | $3.60M | 0.41% | -$11.73M |
| Blossomhill Therapeutics Inc | 0 | 175,000 | +175,000 | $0 | $3.26M | 0.37% | +$3.26M |
| Lyell Immunopharma Inc | 344,025 | 291,353 | -52,672 | $4.83M | $2.85M | 0.32% | -$1.98M |
| Rocket Pharmaceuticals Inc | 1,000,000 | 1,000,000 | 0 | $3.42M | $2.63M | 0.30% | -$790.0K |
| Biodesix Inc | 180,000 | 87,000 | -93,000 | $4.06M | $2.60M | 0.29% | -$1.46M |
| Bridgebio Oncology Therapeut | 700,000 | 630,000 | -70,000 | $5.33M | $2.58M | 0.29% | -$2.75M |
| Okyo Pharma LtdSHS NEW | 375,204 | 1,620,000 | +1,244,796 | $562.8K | $2.09M | 0.24% | +$1.53M |
| Jade Biosciences Inc | 145,000 | 140,463 | -4,537 | $3.22M | $1.97M | 0.22% | -$1.25M |
| Enanta Pharmaceuticals Inc | 125,000 | 125,000 | 0 | $1.82M | $1.65M | 0.19% | -$175.0K |
| Fortress Biotech Inc | 890,000 | 720,000 | -170,000 | $2.72M | $1.54M | 0.17% | -$1.18M |
| Sanuwave Health Inc | 306,140 | 306,140 | 0 | $3.06M | $1.44M | 0.16% | -$1.62M |
| MBX Biosciences, Inc.(MBX) | 260,000 | 20,000 | -240,000 | $14.35M | $1.17M | 0.13% | -$13.18M |
| Obsidian Therapeutics Inc | 0 | 75,755 | +75,755 | $0 | $1.04M | 0.12% | +$1.04M |
| Journey Med Corp | 350,000 | 125,000 | -225,000 | $2.48M | $855.0K | 0.10% | -$1.62M |
| Korro Bio Inc | 0 | 69,348 | +69,348 | $0 | $687.2K | 0.08% | +$687.2K |
| Sionna Therapeutics Inc | 0 | 70,000 | +70,000 | $0 | $368.2K | 0.04% | +$368.2K |
| Adagio Med Hldgs Inc | 18,444 | 18,444 | 0 | $13.4K | $2.8K | 0.00% | -$10.5K |
| Apogee Therapeutics Inc | 390,000 | 0 | -390,000 | $51.76M | $0 | — | -$51.76M |
| Atea Pharmaceuticals, Inc.(AVIR) | 235,000 | 0 | -235,000 | $1.09M | $0 | — | -$1.09M |
| CG Oncology, Inc.(CGON) | 17,789 | 0 | -17,789 | $1.26M | $0 | — | -$1.26M |
| First Tracks Biotherapeutics | 65,000 | 0 | -65,000 | $1.31M | $0 | — | -$1.31M |
| Hemab Therapeutics Hldgs Inc | 47,652 | 0 | -47,652 | $1.75M | $0 | — | -$1.75M |
| Intellia Therapeutics, Inc.(NTLA) | 250,000 | 0 | -250,000 | $4.23M | $0 | — | -$4.23M |
| Palatin Technologies, Inc.(PTN) | 20,500 | 0 | -20,500 | $221.2K | $0 | — | -$221.2K |
| Pasithea Therapeutics Corp.(KTTA) | 2,050,000 | 0 | -2,050,000 | $1.06M | $0 | — | -$1.06M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 185,589 | 0 | -185,589 | $2.01M | $0 | — | -$2.01M |
| Xoma Royalty Corporation | 338,374 | 0 | -338,374 | $14.38M | $0 | — | -$14.38M |